NDC 51662-1487
Glycopyrrolate 0.2 mg per 1 mL injection
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hikma Pharmaceuticals USA Inc.'s NDC 0143-9682.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hikma Farmaceutica (portugal), S.a | Terrugem Sintra, Portugal | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyApr 21, 2023 · 9 inspections, 1 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Jun 6, 2023 · Class III · HF Acquisition Co LLC
Labeling: Label Mix-up
Lots: Lot #: 2205095.1, Exp. Date 7/31/2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Glycopyrronium: every company that makes it
- Form
- injection, intramuscular; intravenous
- Strength
- 0.2 mg per 1 mL
- Approval
- ANDA ANDA090963
- On the market since
- Jan 11, 2020
- Package NDCs
51662-1487-151662-1487-251662-1487-3- Official label
- DailyMed (National Library of Medicine), updated Feb 22, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?